Double scan strategy could sharpen prostate cancer staging
NCT ID NCT07455097
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether combining PSMA-PET/CT and MRI scans can more accurately determine the extent of prostate cancer in men with intermediate- or high-risk disease. Researchers will compare scan results with tissue samples from 600 men who had their prostate removed. The goal is to improve staging and guide personalized treatment decisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PSMA-11 (diagnostic tracer)
What this could lead to
If successful, this could lead to more accurate staging of prostate cancer, helping doctors choose better treatments and avoid unnecessary surgery.
What could go wrong
This is a retrospective analysis, not a controlled trial, so results may not apply to all patients. The imaging techniques are already in use, so the benefit may be modest.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH-RISK PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fortis Hospital
Kolkata, India
-
KU Leuven
Leuven, Belgium
-
Ludwig-Maximilians-University Munich
Munich, Germany
-
Lund University Hospital
Lund, Sweden
-
Marienhospital Herne
Herne, Germany
-
Medical University Vienna
Vienna, Austria
-
San Raffaele University Hospital Milan
Milan, Italy
-
University Hospital Bern
Bern, Switzerland
-
University Hospital Düsseldorf
Düsseldorf, 40225, Germany
-
University Hospital Tübingen
Tübingen, Germany